BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1496545)

  • 1. Increased islet allograft survival after extended culture by a mechanism other than depletion of donor APCs. Lack of correlation between the elimination of donor MHC class II-positive accessory cells and increased transplantability.
    Ketchum RJ; Moore WV; Hegre OD
    Transplantation; 1992 Aug; 54(2):347-51. PubMed ID: 1496545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial class II-positive cell depletion by donor pretreatment with gamma irradiation. Evidence of differential immunogenicity between vascularized cardiac allografts and islets.
    Stegall MD; Tezuka K; Oluwole SF; Engelstad K; Jing MX; Andrew J; Hardy MA
    Transplantation; 1990 Feb; 49(2):246-51. PubMed ID: 2137652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.
    Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K
    Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of rejection of established islet allografts by third-party thyroid allografts and splenic dendritic cells.
    Kover K; Moore WV
    Diabetes; 1991 Jun; 40(6):754-8. PubMed ID: 2040391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells.
    Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 2000 Jan; 69(2):221-6. PubMed ID: 10670630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured neonatal islet transplants in alloxan-treated and spontaneously diabetic rats.
    Hegre OD; Serie JR; Weinhaus AJ; Ketchum RJ; Enriquez AJ; Esteban MM
    Horm Metab Res Suppl; 1990; 25():108-16. PubMed ID: 2088948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allotransplantation of culture-isolated neonatal rat islet tissue. Absence of MHC class II positive antigen-presenting cells in nonimmunogenic islets.
    Hegre OD; Ketchum RJ; Popiela H; Eide CR; Meloche RM; Serie JR; Moore WV
    Diabetes; 1989 Feb; 38(2):146-51. PubMed ID: 2492474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression.
    Markmann JF; Tomaszewski J; Posselt AM; Levy MM; Woehrle M; Barker CF; Naji A
    Transplantation; 1990 Feb; 49(2):272-7. PubMed ID: 2106179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of nonimmunogenic islet allografts to induce donor-specific immunological unresponsiveness [corrected].
    Ketchum RJ; Moyer C; Su HC; Moore WV
    Cell Transplant; 1994; 3(2):179-86. PubMed ID: 8012733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet beta-cells.
    Pipeleers DG; Pipeleers-Marichal M; Vanbrabandt B; Duys S
    Diabetes; 1991 Jul; 40(7):920-30. PubMed ID: 2060728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islet transplantation. Induction of graft acceptance by ultraviolet irradiation of donor tissue.
    Hardy MA; Lau H; Weber C; Reemtsma K
    Ann Surg; 1984 Oct; 200(4):441-50. PubMed ID: 6237621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression.
    Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA
    Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.
    Oluwole OO; Depaz HA; Gopinathan R; Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
    Diabetes; 2001 Jul; 50(7):1546-52. PubMed ID: 11423475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
    Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
    Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.